Jonathan W. Friedberg, M.D., M.M.Sc.

Jonathan W. Friedberg, M.D., M.M.Sc.

Contact Information

James P. Wilmot Cancer Center
601 Elmwood Ave.
Rochester, NY 14642

Appointment: (585) 275-8762

  • Accepting New Patients Accepting New Patients
  • Admits to Strong Memorial Hospital Admits to Strong Memorial Hospital
  • Admits to Highland Hospital Admits to Highland Hospital

Professional Bio

Jonathan W. Friedberg, M.D., is Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Research.



He is a driving force behind the operations of our clinical programs and a key member of the center's lymphoma Specialized Program of Research Excellence, funded by the National Cancer Institute.

Friedberg is a member of the lymphoma committee in the Southwest Oncology Group, and serves as principal investigator on many local and national lymphoma treatment protocols for both Hodgkin lymphoma and non-Hodgkin's lymphoma.

Dr. Friedberg received his medical degree from Harvard Medical School. His postgraduate training included an internship and residency at Massachusetts General Hospital. He also completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in Boston. Dr. Friedberg also has an M.M.Sc. degree from Harvard Medical School in clinical investigation. He holds subspecialty certification in Medical Oncology and Hematology.

His research interests focus on development of novel therapies for patients with lymphoma. Most recently, he was awarded the Scholar in Clinical Research award from the Leukemia & Lymphoma Society, based upon his work with an oral inhibitor of a protein called Syk, which demonstrated efficacy in the treatment of several different forms of lymphoma, and was selected as a plenary presentation at the annual meeting of the American Society of Hematology.

Patient Care Bio

As Director of the Wilmot Cancer Institute, I seek to provide the highest level of compassionate care for patients, ensuring access to novel treatments and clinical trials whenever possible. My background brings the entire continuum of lymphoma experience to patients, from diagnosis through all treatments including autologous stem cell transplantation and survivorship.



We have built a strong team in Rochester to care for patients with lymphoma that is absolutely first rate and internationally recognized. We have expertise in hematopathology, radiation oncology, dermatology and neurology, in addition to hematology and medical oncology. Driving this team toward excellence – and seeing our success – is highly rewarding.

Our understanding of blood cancers in general, and specifically lymphoma, has enabled us to cure a subset of patients – and that attracted me to this specialty. Happily, this fraction of cured patients has substantially increased during my almost 20 years in this field. Since lymphoma can affect anyone – males, females, young patients, older patients and all ethnicities – I am rewarded by the interaction with a variety of patients. Finally, lymphoma is a complex set of diseases that can affect any organ system and I was drawn to that challenge.

My practice team includes Lynn Rich, NP and Anna Morrison, RN.

Conditions I Treat

- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Waldenstrom macroglobulinemia
- Chronic lymphocytic leukemia

Awards & Honors (National)

Lawrence A. Kohn Senior Teaching Fellow | Outstanding Teaching Contributions, Department of Medicine, Univ 2004 - 2006

Awards & Honors (Local)

Faculty Academic Mentoring Award | University of Rochester School of Medicine and Dentistry | University of Rochester 2012
Scholar in Clinical Research | Leukemia and Lymphoma Society 2008 - 2008
America's Top Doctors Selection 2008 - 2008
Jacob Gitleman Award | Gilda's Club and Cancer Action | Rochester, NY 2007 - 2007
Clinical Investigator Career Development Award | Lymphoma Research Foundation 2003 - 2003
Clinical Oncology Research Fellowship " Immunotherapy of Hodgkin's Disease" | Berlex Oncology Foundation 2001 - 2003
Rising stars program for innovative research | Dunkin Donuts and Dana-Farber Cancer Institute Department of Adu 2001 - 2003

Current Appointments

Director - Cancer Center - Primary Administrative
Samuel E. Durand Chair in Medicine - Department of Medicine (SMD)
Professor - Department of Medicine, Hematology/Oncology (SMD) - Primary

Specialties

Hematology - American Board of Internal Medicine
Medical Oncology - American Board of Internal Medicine
Internal Medicine - American Board of Internal Medicine

Education

MS | Clinical Investigation | Harvard Medical School2001
MD | Medicine | Harvard Medical School1994
BA | Biology | Williams College1990

Post-Doctoral Training & Residency

Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute07/01/1997 - 06/01/1999
Residency in Internal Medicine at Massachusetts General Hospital07/01/1995 - 06/01/1997
Internship in Internal Medicine at Massachusetts General Hospital07/01/1994 - 06/30/1995